Massachusetts Financial Services
SCMP

Massachusetts Financial Services’s Sucampo Pharmaceuticals, Inc. SCMP Stock Holding History

Massachusetts Financial Services’s Portfolio SCMP Stock Details SCMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-10,041
Closed -$180K – 902
2017
Q4 		$180K Buy
+10,041
New +$124K ﹤0.01% 840
2016
Q3 		– Sell
-40,372
Closed -$443K – 900
2016
Q2 		$443K Sell
40,372
-2,507
-6% -$28.1K ﹤0.01% 804
2016
Q1 		$469K Sell
42,879
-1,672
-4% -$21.1K ﹤0.01% 785
2015
Q4 		$770K Sell
44,551
-397
-0.9% -$7.12K ﹤0.01% 752
2015
Q3 		$893K Sell
44,948
-724
-2% -$16.6K ﹤0.01% 764
2015
Q2 		$750K Sell
45,672
-815
-2% -$14.1K ﹤0.01% 794
2015
Q1 		$723K Buy
+46,487
New +$721K ﹤0.01% 806

Other funds holding SCMP

GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Massachusetts Financial Services's SCMP Position: Q1 2018 in Review

Massachusetts Financial Services sold out of Sucampo Pharmaceuticals, Inc. (SCMP) in Q1 2018, closing a stake of 10,041 shares — an estimated $180K sold.

Massachusetts Financial Services first reported a position in SCMP in Q1 2015 and held it in 7 quarters. The position peaked at $893K in Q3 2015. 3 funds tracked by Wall St. Rank hold SCMP as of Q1 2018.

  • Massachusetts Financial Services reported no remaining Sucampo Pharmaceuticals, Inc. position as of Q1 2018 after selling out during the quarter.
  • Massachusetts Financial Services sold 10,041 Sucampo Pharmaceuticals, Inc. shares in Q1 2018, an estimated $180K.
  • Massachusetts Financial Services first reported a position in Sucampo Pharmaceuticals, Inc. in Q1 2015 and held it in 7 quarters.
  • Massachusetts Financial Services's Sucampo Pharmaceuticals, Inc. position peaked at $893K in Q3 2015.
  • 3 funds tracked by Wall St. Rank held Sucampo Pharmaceuticals, Inc. as of Q1 2018.

Based on Massachusetts Financial Services's 13F filing for Q1 2018, filed 4 May 2018.